Skip to content
HomeLatest newsJohnson & Johnson named a LinkedIn Top Company for 2019
FINAL LEDE- Johnson & Johnson Named a LinkedIn Top Company for 2019- LinkedIn Top Companies

Johnson & Johnson named a LinkedIn Top Company for 2019

The LinkedIn list recognizes companies in the U.S. where people most want to work. And this year, Johnson & Johnson is also featured on the Brazil, Japan and UK lists.

Share Article
share to

Johnson & Johnson not only strives to provide its employees with industry-leading benefits—such as global parental leave and military leave—but it’s also working to have the world’s healthiest workforce by offering its employees access to programs and services that support personal well-being.

These efforts received special recognition today, when Johnson & Johnson was named to LinkedIn’s Top Companies list, which honors the 50 most sought-after companies to work for nationwide—places where people want to not only work today, but stay into the future.

Inset- Johnson & Johnson Named a LinkedIn Top Company for 2019- LinkedIn Top Companies Logo

The Top Companies list was launched in 2016 to celebrate the organizations making an impact in the work world—and help LinkedIn users consider where they may want to land their next job.

To select the winners, LinkedIn measures the behavior of over a half-billion professionals on its site to give corporations a blended score, focused on four core areas: interest in a company, engagement with employees, job interest and retention. In essence, LinkedIn members cast a “vote” through their interactions on the site.

In addition to making the U.S. list this year, Johnson & Johnson is also proud to announce that it has been named to the Top Companies lists in Brazil, Japan and the UK.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.